214 related articles for article (PubMed ID: 32942976)
21. 4-Phenyl quinoline derivatives as potential serotonin receptor ligands with antiproliferative activity.
Joshi PV; Sayed AA; RaviKumar A; Puranik VG; Zinjarde SS
Eur J Med Chem; 2017 Aug; 136():246-258. PubMed ID: 28499170
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic significance of quinolines: a patent review (2013-2015).
Hussaini SM
Expert Opin Ther Pat; 2016 Oct; 26(10):1201-21. PubMed ID: 27458877
[TBL] [Abstract][Full Text] [Related]
23. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.
Leung E; Pilkington LI; van Rensburg M; Jeon CY; Song M; Arabshahi HJ; De Zoysa GH; Sarojini V; Denny WA; Reynisson J; Barker D
Bioorg Med Chem; 2016 Mar; 24(5):1142-54. PubMed ID: 26853836
[TBL] [Abstract][Full Text] [Related]
25. Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets.
Lauria A; La Monica G; Bono A; Martorana A
Eur J Med Chem; 2021 Aug; 220():113555. PubMed ID: 34052677
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxicity of 2-methyl-1-substituted-imidazo [4,5-g]quinoline-4,9-dione and 7,8-dihydro-10H-[1,4]oxazino[3',4':2,3]imidazo[4,5-g]quinoline-5,12-dio ne derivatives.
Suh ME; Kang MJ; Yoo HW; Park SY; Lee CO
Bioorg Med Chem; 2000 Aug; 8(8):2079-83. PubMed ID: 11003153
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives.
Othman DIA; Selim KB; El-Sayed MA; Tantawy AS; Amen Y; Shimizu K; Okauchi T; Kitamura M
Bioorg Med Chem; 2019 Oct; 27(19):115026. PubMed ID: 31416740
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, structure-activity relationships and mechanism of action of new quinoline derivatives as potential antitumor agents.
Li S; Hu L; Li J; Zhu J; Zeng F; Huang Q; Qiu L; Du R; Cao R
Eur J Med Chem; 2019 Jan; 162():666-678. PubMed ID: 30496987
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity of novel quinoline-docetaxel analogues.
Chen M; Chen H; Ma J; Liu X; Zhang S
Bioorg Med Chem Lett; 2014 Jul; 24(13):2867-70. PubMed ID: 24835987
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents.
Su T; Zhu J; Sun R; Zhang H; Huang Q; Zhang X; Du R; Qiu L; Cao R
Eur J Med Chem; 2019 Sep; 178():154-167. PubMed ID: 31181480
[TBL] [Abstract][Full Text] [Related]
31. Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors.
Ökten S; Aydın A; Koçyiğit ÜM; Çakmak O; Erkan S; Andac CA; Taslimi P; Gülçin İ
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000086. PubMed ID: 32537757
[TBL] [Abstract][Full Text] [Related]
32. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
[TBL] [Abstract][Full Text] [Related]
33. Iodine-catalyzed direct C-H thiolation of imidazo[1,5-a]quinolines for the synthesis of 3-sulfenylimidazo[1,5-a]quinolines.
Wu SS; Feng CT; Hu D; Huang YK; Li Z; Luo ZG; Ma ST
Org Biomol Chem; 2017 Feb; 15(7):1680-1685. PubMed ID: 28134380
[TBL] [Abstract][Full Text] [Related]
34. Biological activities of quinoline derivatives.
Kumar S; Bawa S; Gupta H
Mini Rev Med Chem; 2009 Dec; 9(14):1648-54. PubMed ID: 20088783
[TBL] [Abstract][Full Text] [Related]
35. Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review.
Yadav V; Reang J; Sharma V; Majeed J; Sharma PC; Sharma K; Giri N; Kumar A; Tonk RK
Chem Biol Drug Des; 2022 Sep; 100(3):389-418. PubMed ID: 35712793
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights.
Saxena A; Majee S; Ray D; Saha B
Bioorg Med Chem; 2024 Apr; 103():117681. PubMed ID: 38492541
[TBL] [Abstract][Full Text] [Related]
37. Quinoline-based Compounds with Potential Activity against Drugresistant Cancers.
Li HT; Zhu X
Curr Top Med Chem; 2021; 21(5):426-437. PubMed ID: 32552650
[TBL] [Abstract][Full Text] [Related]
38. Quinoline-based thiazolyl-hydrazones target cancer cells through autophagy inhibition.
Ćurčić V; Olszewski M; Maciejewska N; Višnjevac A; Srdić-Rajić T; Dobričić V; García-Sosa AT; Kokanov SB; Araškov JB; Silvestri R; Schüle R; Jung M; Nikolić M; Filipović NR
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300426. PubMed ID: 37991233
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antiproliferative evaluation of 6-aryl-11-iminoindeno[1,2-c]quinoline derivatives.
Tseng CH; Tzeng CC; Chung KY; Kao CL; Hsu CY; Cheng CM; Huang KS; Chen YL
Bioorg Med Chem; 2011 Dec; 19(24):7653-63. PubMed ID: 22079254
[TBL] [Abstract][Full Text] [Related]
40. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
